drug · antibody
sabirnetug
Phase 2updated 7mo agoby $ABOS Acumen Pharmaceuticals, Inc.🔗 ChEMBL
Phase 2community read0 votes
Antibody drug with a maximum clinical stage of Phase 2, with 1 investigational indication.
indications
indications
Alzheimer's Disease
all catalysts(0)
nothing on the calendar yet
Trials studying sabirnetug
News(1)
- Acumen scraps sole asset after Alzheimer’s fail, plunging stock 80%Acumen will implement cash-saving strategies and assess its options after sabirnetug failed to beat placebo, leaving the biotech without a clinical program.biospace · 21d ago
Data sources
last refreshed 6h ago
Found something off?
comments(0)
5-min edit window · permanent after that